Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment

被引:10
|
作者
Pozdnyakova, Olga [1 ]
Crowley-Larsen, Patricia [2 ]
Zota, Victor [1 ]
Wang, Sa A. [3 ]
Miron, Patricia A. [1 ,2 ]
机构
[1] UMass Mem Med Ctr, Dept Pathol, Worcester, MA 01605 USA
[2] UMass Mem Med Ctr, Dept Hosp Labs, Worcester, MA 01605 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
IN-SITU HYBRIDIZATION; MULTIPLE-MYELOMA; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; CYTOGENETICS; INSIGHTS;
D O I
10.1016/j.cancergencyto.2008.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, cytogenetic studies of plasma cell neoplasms have been hampered by the fact that terminally differentiated plasma cells do not proliferate well in vitro. Although the use of interphase FISH (iFISH) has greatly improved the ability to detect cytogenetic abnormalities, cases with low numbers of neoplastic cells often do not demonstrate abnormalities. Using a four-assay, nine-probe iFISH panel, we compared the abnormality detection rate for overnight unstimulated bone marrow cultures (ONC) to that for plasma-cell enriched fractions obtained with use of CD138-coated immunomagnetic beads (PCE). In the ONC, an abnormality was detected in I I of 29 cases (38%); in the PCE, an abnormality was detected in 30 of 33 cases (91%). For 28 cases in which iFISH results from ONC were compared directly with PCE samples, the overall abnormality rate was 36% for ONC and 89% for PCE (P < 0.01). The conventional GTG-banded chromosome analysis revealed only 2 of 34 cases with an abnormal karyotype (6%); both cases were hyperdiploid. We conclude that the plasma cell enrichment step for iFISH should be incorporated into the routine cytogenetic work-up for all patients with plasma cell neoplasms. (C) 2009 Elsevier Inc. All fights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 50 条
  • [1] Interphase Fluorescence In Situ Hybridization on Selected Plasma Cells is Superior in the Detection of Cytogenetic Aberrations in Plasma Cell Dyscrasia
    Put, Natalie
    Lemmens, Heidi
    Wlodarska, Iwona
    Konings, Peter
    Moreau, Yves
    Hagemeijer, Anne
    Vandenberghe, Peter
    Michaux, Lucienne
    GENES CHROMOSOMES & CANCER, 2010, 49 (11): : 991 - 997
  • [2] EARLY DETECTION OF PLASMA CELL DYSCRASIA IN SERUM PROTEIN ELECTROPHORESIS
    Rebordao, M.
    Francisco, S.
    Silva, M.
    Costa, L.
    HAEMATOLOGICA, 2016, 101 : 783 - 783
  • [3] Antigenic transformation in plasma cell dyscrasia
    Cruse, JM
    Lewis, RE
    Webb, RN
    Sanders, CM
    Tillman, BF
    Beason, KL
    FASEB JOURNAL, 2006, 20 (04): : A216 - A216
  • [4] LICHEN MYXEDEMATOSUS WITH PLASMA CELL DYSCRASIA
    FELDMAN, P
    ARCHIVES OF DERMATOLOGY, 1968, 97 (05) : 606 - &
  • [5] PRIMARY AMYLOIDOSIS (AND PLASMA CELL DYSCRASIA)
    NELSON, CT
    ARCHIVES OF DERMATOLOGY, 1965, 92 (01) : 108 - &
  • [6] Antigenic transformation in plasma cell dyscrasia
    Cruse, Julius A.
    Lewis, Robert E.
    Webb, Rachel N.
    Sanders, Catherine A.
    Tillman, Benjamin F.
    Beason, Kevin
    Lam, John
    Koehler, Jonathan
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 81 (02) : 157 - 161
  • [7] Lobulated and multinuclear plasma cell myeloma is aggressive form of plasma cell dyscrasia
    Bogdanovic, AD
    Jankovic, GM
    Cemerikic, VM
    Strahinja, RM
    Suvajdzic, ND
    Kraguljac, N
    Savic, OS
    Colovic, MD
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1391 - 1395
  • [8] PLASMA-CELL DYSCRASIA IN IDIOPATHIC MYELOFIBROSIS
    DUHRSEN, U
    MEUSERS, P
    BRITTINGER, G
    BLUT, 1986, 53 (03): : 240 - 240
  • [9] Plasma Cell Dyscrasia: A Case Series of a Masquerader
    Elenjickal, Nikhil
    Kulkarni, Chaitanya
    Algeri, Rashmi
    Kothari, Jatin
    Almeida, Alan
    Sirsat, Rashika
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 (03) : 492 - 497
  • [10] KAPOSI SARCOMA AND PLASMA-CELL DYSCRASIA
    LAW, IP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 229 (10): : 1329 - 1331